US Stock MarketDetailed Quotes

CCCC C4 Therapeutics

Watchlist

5.330
-0.200-3.62%

Close Oct 31 16:00 ET

5.330
0.0000.00%

Post 16:02 ET

369.57MMarket Cap-2805P/E (TTM)

C4 Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

C4 Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 4.120M	--
--	2024/Q3	15.362M / 4.600M	--
--	2024/Q2	12.006M / 4.783M	--
--	2024/Q1	3.039M / 9.283M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 4.120M--

--2024/Q315.362M / 4.600M--

--2024/Q212.006M / 4.783M--

--2024/Q13.039M / 9.283M--

Unlock Free Earnings Estimates

Open Account

C4 Therapeutics Earnings Reports

C4 Therapeutics | 10-Q: Quarterly report

Oct 31 07:15 ET

C4 Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 1 07:31 ET

C4 Therapeutics | 10-Q: Q1 2024 Earnings Report

May 8 07:13 ET

C4 Therapeutics | 10-K: FY2023 Annual Report

Feb 22 07:26 ET

Analyst Rating

Updated: Sep 30, 2024

Buy

Buy
50.00%
Hold
50.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall